Precision Biosciences Inc
DTIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357874
No open-market purchases or sales by Precision Biosciences Inc insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $138.9M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Precision Biosciences Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- +18 vs. Q1 2026
- Shares held
- 17.7M
- +1.53M (+9.4%) vs. Q1 2026
- Total value
- $138.9M
- +$50.8M (+57.7%) vs. Q1 2026
- New holders
- 31
- 31 more added
- Sold out
- 13
- 14 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DTIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $138.9M |
| Q1 2026 | 78 | $88.1M |
| Q4 2025 | 69 | $62.8M |
| Q3 2025 | 56 | $25.7M |
| Q2 2025 | 52 | $18.6M |
| Q1 2025 | 48 | $18.1M |
| Q4 2024 | 55 | $14.7M |
| Q3 2024 | 51 | $29.8M |
| Q2 2024 | 47 | $30.8M |
| Q1 2024 | 43 | $42.8M |
| Q4 2023 | 66 | $12.8M |
| Q3 2023 | 77 | $11.8M |
| Q2 2023 | 77 | $23.0M |
| Q1 2023 | 86 | $36.5M |
| Q4 2022 | 102 | $60.1M |
| Q3 2022 | 103 | $67.2M |
| Q2 2022 | 121 | $93.5M |
| Q1 2022 | 153 | $96.6M |
| Q4 2021 | 134 | $233.4M |
| Q3 2021 | 132 | $336.5M |
| Q2 2021 | 131 | $357.6M |
| Q1 2021 | 128 | $313.0M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Precision Biosciences Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −34,442−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −32,281−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −27,684−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,443−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,993−100.0% | Sold out |
| Miller Financial Services LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −182−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |